AG
PASG icon

Algert Global’s Passage Bio PASG Stock Holding History

Algert Global’s Portfolio PASG Stock Details PASG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-3,818
Closed -$95K – 1240
2022
Q3 		$95K Hold
3,818
– – 0.01% 1109
2022
Q2 		$180K Sell
3,818
-156
-4% -$7.29K 0.01% 1043
2022
Q1 		$246K Buy
3,974
+198
+5% +$16.3K 0.02% 1004
2021
Q4 		$480K Buy
3,776
+2,773
+276% +$453K 0.06% 553
2021
Q3 		$200K Buy
+1,003
New +$239K 0.03% 923

Other funds holding PASG

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Algert Global's PASG Position: Q4 2022 in Review

Algert Global sold out of Passage Bio (PASG) in Q4 2022, closing a stake of 3,818 shares — an estimated $95K sold.

Algert Global first reported a position in PASG in Q3 2021 and held it in 5 quarters. The position peaked at $480K in Q4 2021. 67 funds tracked by Wall St. Rank hold PASG as of Q4 2022.

  • Algert Global reported no remaining Passage Bio position as of Q4 2022 after selling out during the quarter.
  • Algert Global sold 3,818 Passage Bio shares in Q4 2022, an estimated $95K.
  • Algert Global first reported a position in Passage Bio in Q3 2021 and held it in 5 quarters.
  • Algert Global's Passage Bio position peaked at $480K in Q4 2021.
  • 67 funds tracked by Wall St. Rank held Passage Bio as of Q4 2022.

Based on Algert Global's 13F filing for Q4 2022, filed 14 Feb 2023.